By Li-Shiun Chen, MD, MPH, ScD, and Laura J. Bierut, MD Posted: August 14, 2019 Dr. Li-Shiun Chen Dr. Laura J. Bierut Combustible tobacco products, primarily cigarettes, continue to be the leading cause of cancer, and in the most recent surveys, an estimated 34.3 million adults smoke (14% of the U.S. adult population).1 Whereas combustible cigarette…

By Raymond Niaura, PhD Posted: April 1, 2019 IN REFERENCE TO: Halpern SD, French B, Small DS, et al.Randomized trial of four financial incentive programs for smoking cessation. N Engl J Med. 2015;372:2108-2117. Dr. Raymond Niaura As has been true for decades, smoking remains the leading cause of preventable morbidity and mortality in the United States.1…

By Carolyn M. Dresler, MD, MPA Posted: March 1, 2019 It is common knowledge that the number one cause of preventable deaths in the world is from tobacco use—overwhelmingly from cigarettes.1 Most of the deaths from tobacco use, particularly from smoking, are from cardiovascular disease, followed by cancer, and then chronic obstructive pulmonary disease (COPD).2…

By Jeffrey Drope, PhD; Cary Adams, MBA; Clifford E. Douglas, JD; Jacqui Drope, MPH; and Sonali Johnson, PhD Posted: December 2018 Clifford E. Douglas There is clear evidence of success in recent global efforts to curb tobacco use, the largest preventable cause of disease and premature death in the world. Since 2012, global cigarette consumption has…

Posted: August 2018 Tobacco harms the health, the treasury, and the collective spirit of Austria. In May 2018, a smoking ban was scheduled to begin in all bars and restaurants in Austria; however, the ban was recently overturned by lawmakers from a new ruling coalition in the government, the People’s Party and the Freedom Party. In…

By K. Michael Cummings, PhD, MPH, andGraham Warren, MD, PhD Posted: April 2018 On July 28, 2017, the U.S. Food and Drug Administration (FDA) announced a new emphasis in the federal government’s regulatory framework toward tobacco product regulation. This new emphasis would focus on nicotine and would support innovations to promote tobacco harm reduction based…

By Douglas Arenberg, MD Posted: February 2018 There has been rapid change over the past decade in the field of lung cancer. Advances such as histology-specific treatments, targeted agents, immunotherapy, screening, and biomarkers dominate scientific journal pages, and rightfully so. Now more than ever, we lung cancer specialists have more tools to work with to…

Editor’s Note: IASLC Lung Cancer News is pleased to publish this article as part of its continuing focus on the expansion of “combustible tobacco” (cigarettes) to include non-combustible products and related issues.* Philip Morris International (PMI), one of the leading international tobacco companies, recently pledged on its website to build a smoke-free future.1 In its…

Posted: April 2017 Opinion-No: Emily Stone, MBBS, MMed There is little doubt that lung cancer patients and the people around them who smoke need to stop. Smoking cessation can improve survival,1 surgical outcomes,2-4 and response to anticancer therapies5 and can reduce the risk of recurrence.6 However, many physicians feel poorly trained and unsure about providing…

Posted: April 2017 By Cynthia L. Kryder, MS Tobacco exposure remains one of the leading preventable causes of premature disease and death in the United States and abroad. Around the world, 6 million people die each year as a result of tobacco exposure, including 480,000 people in the United States. The global costs of smoking…